CVKDResearch•businesswire•
Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients
Sentiment:Neutral (50)
Summary
PONTE VEDRA, Fla.--(BUSINESS WIRE)---- $CVKD #cadrenaltherapeutics--Cadrenal Therapeutics highlights new research on the economic and medical burden associated with oral anticoagulation for LVAD patients.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 12, 2025 by businesswire